About the journal
Cancer Reports is an open-access journal published by Wiley in United States, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,440 USD. Declared review time at DOAJ: 17 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2573-8348
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,440 USD
- Articles in DOAJ
- 1363
- Declared review time
- 17 weeks
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/25738348
Index listings
- DOAJ · 2021-05-28
- MEDLINE · 2018-01-01
- PUBMED · 2023-10-30
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,440 USD
- Declared review time (DOAJ)
- 17 weeks
- Actual review time (measured)
- 216 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1363
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
17weeks
Works in OpenAlex
1687
Last recorded publication year
2026
h-index
32
i10-index
255
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2021-05-28
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 91%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Cancer Rep (Hoboken
- Source type
- journal
- NLM unique ID (PubMed)
- 101747728
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
Show all subjects (50)
- Cancer survivorship and care
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Cancer survivorship and care
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Human auditory perception and evaluation
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Diverse Scientific and Economic Studies
- Breast Cancer Treatment Studies
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Breast Cancer Treatment Studies
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Breast Lesions and Carcinomas
- Lung Cancer Treatments and Mutations
- Breast Lesions and Carcinomas
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Cancer Risks and Factors
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Risks and Factors
- Prostate Cancer Treatment and Research
- Brain Metastases and Treatment
- Prostate Cancer Treatment and Research
- Esophageal Cancer Research and Treatment
- Esophageal Cancer Research and Treatment
- Prostate Cancer Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Multiple and Secondary Primary Cancers
- Prostate Cancer Diagnosis and Treatment
Keywords (DOAJ)
- cancer biology
- clinical oncology
- bioinformatics
- psycho-oncology
- cancer immunology
- anticancer agents
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ